NVP-015

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNVP-015
Drug Alias NameMitoKit-CIIthird generation cyclophilin inhibitors (NeuroVive)third generation cyclophilin inhibitors (Abliva AB)NVP-015BBP-761
ClassificationSmall molecules
Mechanisms of ActionNeuroprotectantsSuccinate dehydrogenase modulators
TargetsSuccinate dehydrogenase
Therapy Area/IndicationsObesityMitochondrial DiseasesCardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbliva AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitopharm LtdFortify Therapeutics IncIsomerase Therapeutics +[4] 
Active IndicationsN/A
Inactive IndicationsObesityMitochondrial DiseasesCardiovascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A